PON1, paraoxonase 1, 5444

N. diseases: 496; N. variants: 29
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population. 26241956 2015
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human Association between Paraoxonase 1 (PON1) Polymorphisms and the Risk of Acute Coronary Syndrome in a North African Population. 26241956 2015
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis. 21629682 2011
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human Paraoxonase 1 (PON1) polymorphisms, haplotypes and activity in predicting cad risk in North-West Indian Punjabis. 21629682 2011
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. 19371607 2009
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human Risk of carotid atherosclerosis is associated with low serum paraoxonase (PON1) activity among arsenic exposed residents in Southwestern Taiwan. 19371607 2009
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human High-level expression of recombinant human paraoxonase 1 Q in silkworm larvae (Bombyx mori). 16331452 2006
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. 16229851 2006
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human High-level expression of recombinant human paraoxonase 1 Q in silkworm larvae (Bombyx mori). 16331452 2006
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes. 16229851 2006
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Therapeutic phenotype CTD_human Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. 16216721 2005
CUI: C1563937
Disease: Atherogenesis
Atherogenesis
0.300 Biomarker phenotype CTD_human Consumption of argan oil may have an antiatherogenic effect by improving paraoxonase activities and antioxidant status: Intervention study in healthy men. 16216721 2005